## Investigation of Choice for Subclinical Atherosclerosis Detection ### Why CIMT Measurement is Correct **Key Point:** Carotid intima-media thickness (CIMT) by B-mode ultrasound is the gold standard non-invasive investigation for detecting and quantifying early atherosclerotic changes before hemodynamically significant stenosis develops. **High-Yield:** CIMT reflects: - Structural remodeling of the arterial wall - Accumulation of smooth muscle cells and lipids in the intima and media - A surrogate marker of subclinical atherosclerosis - Predictive value for future cardiovascular events independent of traditional risk factors **Mnemonic:** CIMT = **C**arotid **I**ntima-**M**edia **T**hickness — measures the distance from the intimal surface to the medial-adventitial interface. **Clinical Pearl:** CIMT >0.9 mm or presence of carotid plaques is associated with increased cardiovascular risk. This measurement is particularly valuable in asymptomatic individuals for risk stratification and guiding preventive therapy intensity. ### Comparison with Other Investigations | Investigation | Detects | Timing | Best Use | |---|---|---|---| | CIMT (B-mode ultrasound) | Intimal thickening, early remodeling | Early, subclinical | Screening asymptomatic individuals | | Carotid duplex Doppler | Hemodynamically significant stenosis, flow velocity | Advanced disease | Symptomatic patients, known stenosis | | CT angiography | Luminal narrowing, plaque calcification | Established disease | Symptomatic stenosis, surgical planning | | Coronary calcium scoring | Coronary calcification burden | Established CAD | Coronary risk assessment, not carotid | **Tip:** Duplex Doppler detects flow abnormalities and stenosis (>50%) but misses early subclinical disease. CIMT is the earliest marker of atherosclerotic change.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.